SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The June 2022 quarter revenue stood at Rs. 5650.10 millions, up 8.97% as compared to Rs. 5185.10 millions during the corresponding quarter last year.A big decline of -47.93% was reported for the quarter ended June 2022 to Rs. 348.90  millions from Rs. 670.00 millions of corresponding previous quarter.A decline of 611.70 millions was observed in the OP in the quarter ended June 2022 from 1158.70 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 5650.10 5185.10 8.97 5650.10 5185.10 8.97 21840.20 19669.80 11.03
Other Income 51.50 57.20 -9.97 51.50 57.20 -9.97 320.40 243.00 31.85
PBIDT 611.70 1158.70 -47.21 611.70 1158.70 -47.21 2883.20 6161.40 -53.21
Interest 33.80 17.70 90.96 33.80 17.70 90.96 82.90 58.30 42.20
PBDT 577.90 1001.70 -42.31 577.90 1001.70 -42.31 2661.00 6103.10 -56.40
Depreciation 109.80 103.20 6.40 109.80 103.20 6.40 432.60 389.20 11.15
PBT 468.10 898.50 -47.90 468.10 898.50 -47.90 2228.40 5713.90 -61.00
TAX 119.20 228.50 -47.83 119.20 228.50 -47.83 571.80 1268.30 -54.92
Deferred Tax -2.40 -6.20 -61.29 -2.40 -6.20 -61.29 1.70 -187.20 -100.91
PAT 348.90 670.00 -47.93 348.90 670.00 -47.93 1656.60 4445.60 -62.74
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 587.10 0.00
PBIDTM(%) 10.83 22.35 -51.55 10.83 22.35 -51.55 13.20 31.32 -57.86

IOL Chem & Pharma Share Price

96.98 -0.90 (-0.92%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×